Diabetic Retinopathy

Over time, high blood sugars can cause damage to retinal vessels and vision loss from diabetic retinopathy.

What is Diabetes Mellitus?

Diabetes is commonly known as elevated blood sugar. It occurs in young people who have trouble producing a substance called insulin that regulates blood sugar, as well as in older people who develop resistance to insulin as they age. Young diabetics are often referred to as Type 1, while older diabetics are ofte referred to as Type 2. There are also some diabetics who exhibit characteristics of both Type 1 and Type 2 diabetes. All types of diabetics suffer similar effects of elevated blood sugar.
When diabetes is uncontrolled it damages blood vessels throughout the body. The longer a person is diabetic and the more poorly the blood sugar levels are controlled, the more likely that person is to suffer blood vessel damage. As diabetes worsens, it first affects the smallest blood vessels, called capillaries, throughout the body. Some of the locations in the body where tiny capillaries are the most important include the kidneys, the nerves in the legs, feet, and hands, and in the light-sensing tissue of the eye called the retina.

What is Diabetic Retinopathy?

The earliest sign of small blood vessel damage in the retina is background diabetic retinopathy, also known as non-proliferative diabetic retinopathy. Background diabetic retinopathy occurs as small blood vessel disease becomes visible in the retina, and your eye doctor can see small aneurysms or hemorrhages (also known as "blood spots") in the retinal tissue at this stage. Most diabetics with background diabetic retinopathy do not know that they have this sign of advancing diabetes, since it does not always affect the vision when it is mildly or moderately severe. However, early detection of background diabetic retinopathy is crucial, as it helps the patient's primary care doctor or endocrinologist (diabetic disease specialist) know the status of the diabetic blood vessel damage throughout the body. The diagnosis of background diabetic retinopathy also lets the patient's eye doctor know that the patient is at a higher risk of vision loss than a patient without background diabetic retinopathy. The guidelines of the American Diabetes Association and American Academy of Ophthalmology reflect that all diabetics should have a dilated eye exam regularly in an effort to detect background diabetic retinopathy while it is still in its early stages.

What is a Diabetic Eye Examination?

When a patient comes to the retinal office for a diabetic eye exam, there are sometimes special imaging tests recommended by the doctor in addition to the dilated eye exam. These tests can include specific pictures of the eye with both regular color digital cameras and special laser cameras. Retinal tomography, or an evaluation of the retinal thickness and the retinal layers, is a unique technology often used to assess the structure and health of the diabetic retina. Fluorescein angiography is another specialized imaging test that allows for detailed visualization of the tiny retinal blood vessels as well as leakage from areas that are diseased. Sometimes an ultrasonic picture of the back of the eye is obtained. During your visit, your doctor will decide which of these tests are important for assessment of the retina. Not every test is recommended at every visit.

What can I do to Preserve Vision?

The cornerstone of saving vision in diabetes remains excellent blood sugar control. Over the last 2 generations, there has been ample, repeated evidence that keeping the blood sugar at an appropriate level, controlling blood pressure, and monitoring cholesterol and fats in the blood are the most effective ways to stave off diabetic retinopathy. It is very important that every diabetic has a good relationship with their primary care team and makes every effort to optimize their diabetic health. A healthy diet, regular exercise several times each week, routine at-home blood sugar monitoring as directed by your diabetic doctor, and ongoing compliance with diabetic medications are the most important part of saving vision in diabetes.

What is Background Diabetic Retinopathy?

If diabetes remains poorly controlled, background diabetic retinopathy advances as there is more and more small blood vessel damage. The small blood vessels continue to collapse and result is varying degrees of retinal ischemia, or poor blood flow to the retinal tissue due to the absence of normal blood vessel supply. Essentially, progressing diabetic retinopathy is like placing a tourniquet on the retina a slowly tightening it. There is currently no technology to restore the lost blood vessels. The lack of these blood vessels itself can cause irreversible vision loss and often limits the vision in diabetics.

What is Diabetic Macular Edema?

, There are two treatable processes that occur as there is less and less normal retinal blood flow. The first is called diabetic macular edema, which means swelling in the retina associated with diabetes. This swelling can blur and distort the vision. The swelling occurs because the walls of the small blood vessels are progressively more damaged in diabetes, and there is leakage of blood and fluid into the cells of the retina.

Read more

What is Proliferative Diabetic Retinopathy?

The second treatable process in diabetic retinopathy is the growth of abnormal new blood vessels in the eye. This process is called proliferative retinopathy. The abnormal new blood vessels in the eye probably appear in response to progressive absence of normal blood vessels, and this is an even more ominous process than diabetic macular edema. Often there is both diabetic macular edema and proliferative diabetic retinopathy in the same patient at the same time. The abnormal new blood vessels seen in proliferative retinopathy are fragile and often will bleed into the vitreous jelly filling the back of the eye. This process is called vitreous hemorrhage, and patients will often see hundreds of spots, swirls, or lines when vitreous hemorrhage begins. Sometimes the hemorrhage can be so dense that there is severe blurring of vision. As the abnormal new blood vessels continue to grow, they get denser and thicker. This process can lead to tugging or traction on the retina, and that is termed a diabetic tractional retinal detachment. Diabetic retinal detachment is the most serious and advanced stage of diabetic retinopathy. Abnormal new blood vessel growth in the eye can be treated in its earlier stages with laser therapy. The laser technique is much different than that applied to diabetic macular edema.

Read more

What is a Vitreous Hemorrhage?

Patients with diabetes develop weak blood vessels in the retina that are prone to bleeding. If bleeding occurs into the vitreous cavity, patients will see many tiny floaters and develop moderate to severe vision loss. The blood inside the eye doesn't harm the eye but it does block the vision. Blood inside the eye will sometimes absorb within a few weeks or months. When the blood absorb the vision improves. If the blood doesn't asborb, vitrecotmy surgery can be performed to improve the vision. Because of the risk of surgery, most surgeons wait anywhwere from one month to 6 months depending on the situation to see if the blood will clear without surgery.

Read more

What is a Diabetic Tractional Retinal Detachment?

Patients with proliferative diabetic retinopathy sometimes develop a tractional retinal detachment. This can occur when scar tissue grows on the surface of the retina and then contracts or is pulled forwward in the eye by the vitreous. When this happens, the retina, which is stuck to the diabetic scar tissue, pulls away from the back of the eye and away from its blood supply. The vision declines and the retina suffers. Tractional retinal detachments can usually be prevented if sufficient pan-retinal laser is administered before the scar tissue progresses. Once there is a tractional retinal detachment surgery can be helpful.

Read more

Diabetic Retinopathy NEWS

Below are current articles from a Google News Feed on Diabetic Retinopathy

Diabetic Retinopathy Market to Reach USD 13.04 billion By 2026 | Reports And Data  GlobeNewswire

Factors contributing to high CAGR are growing prevalence of diabetes along with rising incidence of blindness. Moreover, increase in purchasing power and the ...

New Treatment Approved for Diabetic Condition Leading to Blindness  Healthline

The drug Eyela can be used to treat the early stages of diabetic retinopathy, reducing the chances of serious vision loss.

Dr. earns award for work on diabetes eye ailment  Oneonta Daily Star

Dr. Konika Sharma, a third-year internal medicine resident at Bassett Medical Center, earned the 2019 E. Donnall Thomas Research Day Outstanding Research ...

How diabetes can affect the eyes  Open Access Government

With diabetes on the increase in the UK, Dr Louise Gow, at The Royal National Institute of Blind People (RNIB) explains how the condition can affect eyes.

Performance of a Deep-Learning Algorithm vs Manual Grading for Detecting Diabetic Retinopathy in India.  DocWire News

Abstract IMPORTANCE: More than 60 million people in India have diabetes and are at risk for diabetic retinopathy (DR), a vision-threatening disease.

Diabetic retinopathy: check the epidemic  Deccan Herald

Diabetic Retinopathy is one of the leading causes of vision loss in people with diabetes, especially the working age group.

Intravitreal injections can lead to cataract complications  Healio

Ocular Surgery News | In the past decade, intravitreal injections have transformed the way that we treat retinal disease, particularly vascular issues, with ...

Dr. Haqqani: Diabetic retinopathy diagnoses expected to increase  Midland Daily News

Diabetic retinopathy (DR) is recognized as the leading cause of vision impairment and blindness among those within working age (25 to 74). The Centers for ...

Study shows OCTA detects changes in diabetic eyes sooner than OCT  Healio

VANCOUVER, British Columbia — OCT angiography was found to be more useful than OCT to detect changes in the eyes of patients with diabetes, according to ...

Eylea approved for all forms of diabetic retinopathy in the US  Diabetes.co.uk

The drug treatment Eylea has been given approval for all stages of diabetic retinopathy in America following a successful clinical trial. In the UK, Eylea, which is ...

The global uveitis drugs market size at a CAGR of around 7% during 2019-2023  PRNewswire

NEW YORK, June 17, 2019 /PRNewswire/ -- About this market Several risk factors associated with uveitis had been a challenge during the diagnosis of eye...

Cardiovascular Impact of 10 Year Lifestyle Interventions In Diabetics  MD Magazine

Osama Hamdy, MD, PhD, discusses the impact of a 10-year study observing the impact of lifestyle interventions among diabetes patients in real-world clinical ...

Rocklatan approval tops recent FDA ophthalmology news  Healio

From new drugs to new indications for existing drugs, the FDA has approved multiple products in the ophthalmology sphere in the first half of 2019.Here are the ...

Lipid-lowering medications are associated with lower risk of retinopathy and ophthalmic interventions among US patients with diabetes  MD Linx

In the U.S. population, researchers assessed the effect of lipid-lowering medications on diabetic retinopathy and diabetic complications requiring intervention.

Can an eye exam reveal Alzheimer's risk? - Harvard Health Blog  Harvard Health

Looking for clues about the health of your brain? You might want to pay a visit to your eye doctor. Research increasingly links common eye conditions ...

Data review: Adults in upstate New York with diabetes better managing their disease  Buffalo News

Adults in upstate New York who have diabetes are better at managing their disease than they were just a few years ago, according to a review of self-reported ...

Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market to Expand Substantially Owing to Technological Innovations During 2015 – 2021  Kentucky Journal 24

Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is ...

Diabetic retinopathy benefits linked to statin medication  Insight News

Taiwanese researchers have discovered that patients on statin medication have a reduced risk of developing diabetic retinopathy (DR) and dyslipidemia, ...

EyePACS LLC Announces Surpassing 5 Million Diagnostic Retinal Images in its Comprehensive Retinal Assessment Database  Yahoo Finance

EyePACS LLC surpasses the 5 million fundus images in telemedicine provider database SANTA CRUZ, Calif. , June 12, 2019 /PRNewswire/ -- EyePACS LLC a ...

Researchers Study Improvement in Patient Compliance and Screening Efficacy by Using the EyeArt AI Eye Screening System for Detecting Diabetic Retinopathy  Yahoo Finance

Key Scientific Findings to Be Presented by Diabetes Experts at the American Diabetes Association Scientific Sessions.

Stem cell treatment: What could possibly go wrong with procedure?  Ophthalmology Times

Stem cell therapies for ocular diseases often are of unproven efficacy and may result in vision loss, notes one surgeon. Reviewed by Thomas A. Albini, MD.

REWIND: Dulaglutide reduces CV, renal risk in broad type 2 diabetes population  Healio

SAN FRANCISCO — In a large cohort of adults with type 2 diabetes with and without established cardiovascular disease, the once-weekly GLP-1 receptor ...

'Alarming' Complications in 20-Year-Olds With Type 2 Diabetes  Medscape

'I think we need to recognize that...in these younger kids we probably need even more aggressive management than many adults with type 2 diabetes,' says the ...

Subfoveal choroidal thickness in diabetic macular edema | OPTH  Dove Medical Press

Dalia Mohamed Fawzy Mohamed,1 Nihal Adel Hassan,2 Amr Abdellatif Osman,2 Moataz Hamed Osman2 1Department of Ophthalmology, National Institute of ...

Type 2 diabetes: Ways to help reverse the condition  Express

TYPE 2 diabetes is formally known as adult-onset diabetes and involves high blood sugar, insulin resistance and a lack of insulin. Long term complications ...

Brazilian Develops Eye Drops to Stop Diabetes-Related Retinal Damage  The Rio Times

Retinopathy is a common complication in diabetic patients. The condition is caused by excess glucose in the blood, which damages blood vessels inside the ...

Diabetic eye scans under threat, due to legal judgment  Independent.ie

The viability of the national diabetic retinopathy screening programme, Diabetic Retina Screen, is now in danger, its clinical director has warned - due to the ...

Diabetics, don’t lose sight of this emerging disease  The Hindu

Along with screening for Retinopathy of Prematurity (ROP), another pilot initiative taken up is the screening for diabetic retinopathy (DR), which is damage ...

AI detecting diabetic eye disease - SHINE News  Shine News

Artificial intelligence is being used in early screening for diabetic retinopathy, the most common form of diabetic eye disease, local medical experts said on ...

Conference Highlights: ADA 2019  Physician's Weekly

Jun 11, 2019 | Articles | 0 |. New research was presented at ADA 2019, the 79th Scientific Sessions of American Diabetes Association, from June 7-11 in Los ...

Expert Panel Defines CGM Time-in-Range Targets  MedPage Today

SAN FRANCISCO -- Patients with diabetes who use continuous glucose monitoring (CGM) systems should stay in the recommended range for around ...

10 Israeli Health Firms Invited to Improve U.S. Healthcare  TheTower.org

Ten Israeli companies were chosen to present at the GlobalSTL Health Innovation Summit, which brings transformational tech to the U.S. healthcare industry.

Fluocinolone acetonide 0.19 mg intravitreal implant improves foveal th | IMCRJ  Dove Medical Press

Fluocinolone acetonide 0.19 mg intravitreal implant improves foveal thickness and reduces treatment burden for up to 1 year in eyes with persistent diabetic ...

Global Diabetic Retinopathy Market 2019– Outlook Growths, Growth Factors, Top Companies, Research Method and Forecasts 2024  TheSportMail

Global Diabetic Retinopathy market 2019 research report on the Diabetic Retinopathy market presents a brief scenario and the dynamics principal in the global ...

FDA Approves New Injection for Diabetic Retinopathy  dLife.com

Regeneron Pharmaceuticals, Inc. announced yesterday that the U.S. Food and Drug Administration (FDA) has approved EYLEA® (aflibercept) Injection to treat ...

Global Proliferative Diabetic Retinopathy Market to Incur Rapid Extension During 2017-2026  Market Reporter

Proliferative diabetic retinopathy prevails as leading cause of blindness across industrialized countries worldwide. Although remarkable advancements have ...

Earlier Detection of Diabetic Retinopathy with Smartphone AI  Michigan Medicine

Pairing a smartphone to capture retinal images with artificial intelligence to interpret them may help overcome barriers to ophthalmic screening for the disease.

Drs. Oz & Roizen: Kids eat better by knowing benefits; gastric bypass and diabetes  The Union Leader

DEAR DOCS: I can't get my 9-year-old to eat vegetables — and we set a good example, sneak them into smoothies, give them funny names, all the stuff that ...

Alimera Sciences Announces Launch of Direct-to-Patient Marketing Campaign to Raise Awareness and Educate Consumers on Diabetic Macular Edema and ILUVIEN®  GlobeNewswire

Pilot program to be initiated in four U.S. cities leveraging radio, print and social media channels, with potential for future expansion. ILUVIEN's CONTINUOUS ...

Are Carrots Good for Your Eyes?  Healthline

Carrots are commonly claimed to keep your eyes healthy, but you may wonder whether this idea is supported by science. This article tells you whether carrots ...

Diabetic Retinopathy Exams in Primary Care  Physician's Weekly

May 13, 2019 | Articles | 0 |. Unfortunately, in most practices, less than 50% of people with diabetes make it to an eye care specialist for a critical, sight-saving ...

Diabetic Retinopathy 2019 Global Market Outlook,Research,Trends and Forecast to 2025  Market Reporter

Diabetic Retinopathy Industry 2019. Description:- Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the ...

Global Diabetic Retinopathy Market to Garner USD 9.3 Billion By 2024: Zion Market Research  Market Research Journal

Diabetic Retinopathy Market report provides the statistical analysis of “Diabetic Retinopathy Market – by Type (Non-Proliferative Diabetic Retinopathy and ...

Globally Diabetic Retinopathy market expected to reach multi billion dollars by 2024  The Scripps Voice

Diabetic Retinopathy Market report covers the disease overview, definition, classification, symptoms, ethology, pathophysiology and diagnostic methods.

Global Diabetic Retinopathy Treatment Market 2019 – Regeneron Pharmaceuticals, ThromboGenics, Genentech, Bayer Healthcare, Alimera Sciences  Market News 24

Global Diabetic Retinopathy Treatment Market Research Report comprises holistic business information and changing trends in the market that enables users to ...

Diabetes Type 2 Market and Forecast Analysis to 2024  Yahoo Finance

NEW YORK , June 4, 2019 /PRNewswire/ -- DISEASE OVERVIEW Diabetes occurs when the body cannot use sugars properly due to impaired insulin ...

Diabetic Retinopathy Market Survey & Global Status by Abbott Laboratories, Alimera Science, Allergan plc, Ampio Pharmaceuticals.  Global Industry Journal

Astute analysis of Global Diabetic Retinopathy Market and authentic forecasts of ever-changing trends, consumer tendencies, and market size. The Global ...

Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal en | JIR  Dove Medical Press

Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells Youde Jiang, Jena J SteinleDepartment of Ophthalmology, Visual and ...

Ophthalmic Sutures Market value to hit $443 Million by 2025: Global Market Insights, Inc.  GlobeNewswire

Asia Pacific ophthalmic sutures market is set to register over 6% CAGR from 2019 to 2025 supported by rising elderly population base that suffers from eye ...

Vitamin D deficiency and glycemic control among patients with type 2 d | DMSO  Dove Medical Press

Hussain Darraj,1 Mohammed Badedi,1 Kirsten R Poore,2 Abdulrahman Hummadi,1 Abdullah Khawaji,1 Yahia Solan,3 Ibrahim Zakri,1 Abdullah Sabai,1 Majid ...

AI Supports Diagnosis of Diabetic Retinopathy  Technology Networks

Technology Networks is an internationally recognised publisher that provides access to the latest scientific news, products, research, videos and posters.

FDA approves Regeneron's Eylea for diabetic retinopathy  Healio

The FDA has approved Regeneron Pharmaceuticals' aflibercept injection, Eylea, for the treatment of all stages of diabetic retinopathy.The approval was based ...

Global Proliferative Diabetic Retinopathy Market 2019 Intas Pharmaceuticals, Santen Pharmaceutical  News Magazine 24

The report on the Global Proliferative Diabetic Retinopathy Market offers complete data on the Proliferative Diabetic Retinopathy market. Components, for ...

Diabetic Retinopathy & Eye Screenings  Endocrinology Advisor

Patients with type 1 or type 2 diabetes are at risk for developing diabetic retinopathy. Eye screening programs are important to preserve vision.

Applied Therapeutics to Present Data Highlighting AT-001 for the Treatment of Diabetic Cardiomyopathy in Late Breaking Session at the American Diabetes Association 79th Annual Scientific Sessions  GlobeNewswire

AT-001, a novel, potent and selective aldose reductase inhibitor, is expected to start a pivotal study later this year.

Archived Posts  News Earlier

Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Analysis Report 2019-2024: Novartis, Bayer Healthcare, Roche.

Statins May Prevent Diabetic Retinopathy in People with Diabetes  EndocrineWeb

Individuals with diabetes who were taking a statin for high blood cholesterol have the added benefit of reducing their risk of developing diabetic retinopathy, and ...

Smartphone AI Effectively Detects Diabetic Retinopathy  DocWire News

Researchers have recently shown that together, AI software and a smartphone camera can offer a convenient screening system for diabetic retinopathy (DR).

Diet Soda Linked to Increased Risk for Diabetic Retinopathy  Medscape

Drinking diet soda may increase the risk for proliferative diabetic retinopathy — a severe type of diabetic eye disease that can lead to blindness — according to a ...

Glycemic Threshold for Diabetic Retinopathy Differs By Ethnicity  Diabetes In Control

Future studies should be designed to assess sociodemographic variables and how these influence the risk of diabetic retinopathy and glycemic threshold.

Tongan blindness prevention programme receives recognition  RNZ

A Tongan programme to prevent diabetes-related blindness has received praise from the Queen Elizabeth Diamond Jubilee Trust.

Proliferative Diabetic Retinopathy Market to Expand At 9.5% CAGR from 2017-2026, Due To Growing Prevalence of Diabetes – TMR  GlobeNewswire

Unhealthy Eating Habits have led to the Rising Incidence of Proliferative Diabetic Retinopathy.

Disease Pathways for Diabetic Retinopathy Vary Between Patients  Endocrinology Network

Diabetic retinopathy is the leading cause of blindness among working adults in the United States, but disease pathways may vary between patients, new ...

Global Diabetic Retinopathy Market 2019 – Overview, Research Analysis, Growth Opportunity and Forecast up to 2024  The Industry Journal

Profound comprehension of the Global Diabetic Retinopathy Market emphasizing product demand, sales volume, revenue outcome, and market scope.

Eyenuk launches AI diabetic retinopathy screening service  Healio

Eyenuk has launched its EyeScreen Human + AI Diagnostic *Service* for diabetic retinopathy, according to a press release.The artificial intelligence technology ...

Smartphone algorithm combined with paper funnel can detect ear infection  MobiHealthNews

Using a smartphone and a paper funnel, researchers from the University of Washington have created a system that can detect fluid in the middle ear, which ...

More Diabetic Retinopathy Screening? Primary Care May Be the Answer  MedPage Today

Primary care may be an untapped resource for diabetic retinopathy screening, a new study suggested. In a survey of over 3,200 adults with diabetes, nearly 88% ...

Diet soda consumption associated with increased risk of diabetic retinopathy  Healio

Researchers found that patients with diabetes who consumed more than four cans per week of a diet soft drink had a more-than-twofold risk of having ...

Global Diabetic Retinopathy Treatment Market Global key Players Alimera Sciences, Kowa Company Ltd., Bausch Health, Abbott, Pfizer Inc., IRIDEX Corporation, Lumenis  industryreports24.com

The Global Diabetic Retinopathy Treatment Market research report is a superior tool which helps business to take unbiased choices, to handle the hardest ...

Eyenuk debuts AI-assisted diabetic retinopathy screening  Medical Design & Outsourcing

Artificial intelligence vision-screening company Eyenuk (Woodland Hills, Calif.) said it has launched an AI-powered diagnostic *service* for diabetic retinopathy.

VIDEO: AI-based diabetic retinopathy screening device shows 'exceptional results'  Healio

VANCOUVER, British Columbia — Kaushal Solanki, PhD, founder and CEO of Eyenuk Inc., discusses study results of the EyeArt AI Screening System for ...

Anti-VEGF injections may play increasing role in treatment of diabetic retinopathy  Healio

Ocular Surgery News | Patients with diabetic macular edema and moderately severe to severe nonproliferative diabetic retinopathy, as determined on the ...

FDA Clears AI Device for Diabetic Retinopathy Diagnosis  DARKDaily.com - Laboratory News

FDA clearance of an AI system for diagnosing diabetic retinopathy using retinal images shows medical potential of deep learning and algorithmic analysis.

Expecting Huge Growth for Diabetic Retinopathy Drug Market 2026 Focusing Top Key Players like – Roche, Moore Drug Company, Regeneron Pharmaceuticals Inc., Bayer Healthcare, ThromboGenics, Actavis PLC, Sirnaomics Incorporation, Parexel International Corp  Healthcare News

Global Diabetic Retinopathy Drug Market Size, Status and Forecast 2024, is the latest report added to the large report database of QYReports which sheds light ...

India Fights Diabetic Blindness With Help From A.I.  The New York Times

A partnership with Google is part of a global effort to build and deploy systems that can detect signs of illness and disease in medical scans.

Clinician-AI combination is best in diagnosing diabetic retinopathy  Health Data Management

Assisted by a deep-learning algorithm, physicians were able to more accurately diagnose diabetic retinopathy—a potentially blinding eye disease—than either a ...

Google, Verily using AI to screen for diabetic retinopathy in India  Healthcare IT News

The machine learning algorithm can also help with screening for diabetic macular edema, a boon for patients in a country where physicians are in short supply.

Aerpio Shares Plummet after Lead Candidate Fails Phase IIb Diabetic Retinopathy Trial  Genetic Engineering & Biotechnology News

Aerpio Pharmaceuticals acknowledged the failure of its lead pipeline candidate in a Phase IIb trial in patients with moderate to severe non-proliferative diabetic ...

Digital image processing software for diagnosing diabetic retinopathy | OPTH  Dove Medical Press

Tanapat Ratanapakorn,1 Athiwath Daengphoonphol,2 Nawapak Eua-Anant,2 Yosanan Yospaiboon1 1KKU Eye Center, Department of Ophthalmology, Faculty ...

Time In Range Associated With Diabetic Retinopathy  Diabetes In Control

By assessing time in target glucose range using a continuous glucose monitor, a person with type 2 diabetes can get a measure risk for diabetic retinopathy.

Diabetic Retinopathy: Assessing the Armamentarium for Improved Detection and Treatment  Healio

Learning Objectives: Upon successful completion of this activity, participants should be better able to: Utilize imaging techniques that aid in the early diagnosis, ...

Tonga praised for diabetes blindness screening  Matangi Tonga

Tonga has been commended for its progress in treating blindness caused by diabetes, as part of a program supported by The Queen Elizabeth Diamond Jubilee ...

Using artificial intelligence to automate screening for diabetic retinopathy  Ophthalmology Times

A Deep Learning System (DLS) is an advanced form of artificial intelligence (AI) that can start with a mix of images from different groups and then learn to ...

Deep learning-enhanced device detects diabetic retinopathy  Medical Xpress

(HealthDay)—A deep learning-enhanced device can accurately detect diabetic retinopathy (DR), according to a study published online Feb. 14 in Diabetes Care ...

Regeneron Pharmaceuticals, Inc. - Consenus Indicates Potential 27.5% Upside  DirectorsTalk Interviews

Regeneron Pharmaceuticals, Inc. found using ticker (REGN) have now 21 analysts covering the stock with the consensus suggesting a rating of 'Buy'. The.

BLOG: Laser still has an important role in diabetic eye disease  Healio

Ophthalmology Blogs | Mali | There is no question that the introduction of anti-VEGF agents has dramatically changed the landscape of how surgeons approach ...

Diabetic Retinopathy Market to Hit $12 Billion by 2025: Global Market Insights Inc.  PRNewswire

SELBYVILLE, Del., April 29, 2019 /PRNewswire/ -- Europe diabetic retinopathy market was valued at 2.3 billion in 2018. Considerable revenue size can be...

Global Diabetic Retinopathy Market Expected to Reach USD 9.3 Billion By 2024: Zion Market Research  GlobeNewswire

According to the report, the global diabetic retinopathy market was valued at approximately USD 6 billion in 2017 and is expected to generate revenue of around ...

Statins, Fibrates Lower Diabetic Retinopathy Risks in Diabetes  Medscape

Patients with type 2 diabetes given statin or fibrate lipid-lowering therapy have both a reduced risk of developing diabetic retinopathy and being treated for the ...

Opticians in Oldham boosts customer services with £80000 refit  Bdaily

A LOCAL opticians is currently completing a major store expansion, representing a £80,000 investment into Oldham's community healthcare provision.

Broadband Update: Complex Platforms Make Telehealth More Than Video  Daily Yonder

Treating a patient remotely combines the power of medical devices, hardware, internet technology, and old-fashioned medicine to provide a continuum of care.

Diabetic Retinopathy Market 2019 to Surge at a CAGR of +16% by 2025 According to New Research Profiling Top Key Players- Bayer AG, Boehringer Ingelheim GmbH, Vitreoretinal Technologies, Novartis AG, Alimera Sciences, Hoffmann-La Roche  Global Market Research

Diabetic Retinopathy is the most common diabetic eye disease and a leading cause of blindness in American adults. It is caused by changes in the blood ...

Analysis of Patient-Reported Barriers to Diabetic Retinopathy Follow-Up  Healio

Ophthalmic Surgery, Lasers and Imaging Retina | BACKGROUND AND OBJECTIVES:Close follow-up of diabetic retinopathy (DR) has been linked to improved ...

Statin Therapy Reduces Risk for Diabetic Retinopathy in T2DM  Monthly Prescribing Reference

For Taiwanese patients with type 2 diabetes and dyslipidemia, statin therapy is associated with a reduced risk for diabetic retinopathy, according to a study ...

One-Year Results from Positive Phase 3 EYLEA Trial in Diabetic Retinopathy Presented at Angiogenesis Symposium  BioSpace

Published: Feb 09, 2019. TARRYTOWN, N.Y., Feb. 9, 2019 /PRNewswire/ --. Trial showed that early intervention with EYLEA improved diabetic retinopathy ...

Top 6 Trends to Cure Healthcare Startup Problems in 2019  Healthcare Tech Outlook

With the gradual addition of AI, Chatbots, and Robotics in various process of healthcare sector last year, the need for the update has set ablaze...

Global Diabetic Retinopathy Treatment Market to See Incredible Growth 2025 By Major Players Merck KGaA. F. Hoffmann-La Roche Ltd, Pfizer, Inc., Sandoz International GmbH, Novasep, Medtronic, Lonza,, AbbVie Inc., Sanofi, Boehringer Ingelheim International GmbH  StockNewsMagazine

Rising growth of the diabetic and geriatric population all over the world, leading to Diabetic Retinopathy is one of the leading causes in the rise of this market.

RAAS Activation Linked to Vascular Stiffening in T1D With Proliferative Retinopathy  Endocrinology Advisor

In patients with long-standing T1D and proliferative diabetic retinopathy, renin-angiotensin-aldosterone system activation may be associated with vascular ...

Diabetic Retinopathy Treatment Market Trends & Forecasts, Growth by Top Companies, Region, Application, Driver 2025  Gadget247News

The report consists of current trends as far as the Global Diabetic Retinopathy Treatment Market is concerned. It helps in the decision-making to the market ...

Global Proliferative Diabetic Retinopathy Market Is Expected To Grow with a Healthy CAGR During 2017-2026  Market Research Gazette

ResearchMoz incorporate new survey report “Proliferative Diabetic Retinopathy Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast ...

» Load more

What about Resources?

Dr. Pautler's Blog

This site is not designed to and does not provide medical advice, professional diagnosis, opinion, treatment or services to you or to any other individual. Through this site and linkages to other sites, The information provided in this site, or through linkages to other sites, is not a substitute for medical or professional care, and you should not use the information in place of a visit, call consultation or the advice of your physician or other healthcare provider.

IF YOU BELIEVE YOU HAVE A MEDICAL EMERGENCY, YOU SHOULD IMMEDIATELY CALL 911 OR YOUR PHYSICIAN. If you believe you have any other health problem, or if you have any questions regarding your health or a medical condition, you should promptly consult your physician or other healthcare provider. Never disregard medical or professional advice, or delay seeking it, because of something you read on this site or a linked website. Never rely on information on this website in place of seeking professional medical advice. You should also ask your physician or other healthcare provider to assist you in interpreting any information in this Site or in the linked websites, or in applying the information to your individual case.

Medical information changes constantly. Therefore the information on this Site or on the linked websites should not be considered current, complete or exhaustive, nor should you rely on such information to recommend a course of treatment for you or any other individual. Reliance on any information provided on this Site or any linked websites is solely at your own risk.